Clinical Trial Update: Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update investigates recombinant human endostatin in combination with XELOX therapy for advanced colorectal cancer (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Recombinant human endostatin (recombinant human endostatin)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: Quality of Life | Phase 2, Phase 3 | Status: UNKNOWN